Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC

Autor: Simon A. Keek, Esma Kayan, Avishek Chatterjee, José S. A. Belderbos, Gerben Bootsma, Ben van den Borne, Anne-Marie C. Dingemans, Hester A. Gietema, Harry J. M. Groen, Judith Herder, Cordula Pitz, John Praag, Dirk De Ruysscher, Janna Schoenmaekers, Hans J. M. Smit, Jos Stigt, Marcel Westenend, Haiyan Zeng, Henry C. Woodruff, Philippe Lambin, Lizza Hendriks

Publikováno v: Therapeutic Advances in Medical Oncology, Vol 14 (2022)

Introduction: Despite radical intent therapy for patients with stage III non-small-cell lung cancer (NSCLC), cumulative incidence of brain metastases (BM) reaches 30%. Current risk stratification methods fail to accurately identify these patients. As

Externí odkaz: https://doaj.org/article/9a92cc6300fc4c7c9959e69e2b3229ec

Computed tomography-based radiomics for the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer patients treated with immune checkpoint inhibitors

Autor: Fariba Tohidinezhad, Dennis Bontempi, Zhen Zhang, Anne-Marie Dingemans, Joachim Aerts, Gerben Bootsma, Johan Vansteenkiste, Sayed Hashemi, Egbert Smit, Hester Gietema, Hugo JWL. Aerts, Andre Dekker, Lizza E.L. Hendriks, Alberto Traverso, Dirk De Ruysscher

Publikováno v: European Journal of Cancer, 183, 142-151. Elsevier Ltd.
European Journal of Cancer, 183, 142-151. ELSEVIER SCI LTD
Tohidinezhad, F, Bontempi, D, Zhang, Z, Dingemans, A-M, Aerts, J, Bootsma, G, Vansteenkiste, J, Hashemi, S, Smit, E, Gietema, H, Aerts, H J WL, Dekker, A, Hendriks, L E L, Traverso, A & de Ruysscher, D 2023, ' Computed tomography-based radiomics for the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer patients treated with immune checkpoint inhibitors ', European Journal of Cancer, vol. 183, pp. 142-151 . https://doi.org/10.1016/j.ejca.2023.01.027
European Journal of Cancer, 183, 142-151. Pergamon

Introduction: Immunotherapy-induced pneumonitis (IIP) is a serious side-effect which requires accurate diagnosis and management with high-dose corticosteroids. The differ-ential diagnosis between IIP and other types of pneumonitis (OTP) remains chall

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4323d7bfdd7d4fc3c08583aaf0494b2
https://pure.eur.nl/en/publications/18c8f75f-c320-414f-920e-fb54ae6bd1aa

Chest tube drainage versus video-assisted thoracoscopic surgery for a first episode of primary spontaneous pneumothorax

Autor: Y. Vissers, Michiel H. M. Gronenschild, Karel W.E. Hulsewé, Jos G. Maessen, Erik R. de Loos, Jean H.T. Daemen, Pieter W.J. Lozekoot, Gerben Bootsma

Publikováno v: European Journal of Cardio-Thoracic Surgery. 56(5):819-829

Summary Primary spontaneous pneumothorax affects up to 28 patients per 100 000 population yearly and is commonly resolved by chest tube drainage. However, drainage is also known to be associated with ipsilateral recurrence rates ranging from 25% to 4

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbceee3707c18ad838a6413b13c1ee98
https://doi.org/10.1093/ejcts/ezz116

Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450)

Autor: Anne-Marie C. Dingemans, Linda van Eijsden, Bart Reymen, Gerben Bootsma, Ruud Houben, Angela van Baardwijk, Rinus Wanders, Dirk De Ruysscher, Lizza E.L. Hendriks, Cordula Pitz

Publikováno v: Journal of Thoracic Oncology, 13(12), 1958-1961. Elsevier Science

Introduction: Two randomized studies have shown an increased progression-free survival (PFS) by adding a radical local treatment to systemic therapy in responding patients with oligometastatic NSCLC, but long-term data are lacking. We updated the res

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d66ed740a333938230b414a2a8fa3c39
https://doi.org/10.1016/j.jtho.2018.07.098

Are patients with stage III non-small cell lung cancer treated with chemoradiotherapy at risk for cardiac events? Results from a retrospective cohort study

Autor: Anne-Marie C. Dingemans, Ruud Houben, Lizza E.L. Hendriks, Bastiaan Kietselaer, Juliette H R J Degens, Gerben Bootsma, Dirk De Ruysscher, Annemie M. W. J. Schols, Ellen Huijbers

Publikováno v: BMJ Open, 10(9):036492. BMJ Publishing Group
BMJ Open, 10(9):e036492. BMJ Publishing Group
BMJ Open, Vol 10, Iss 9 (2020)
BMJ Open

ObjectivesDyspnoea is one of the symptoms frequently encountered after treatment with chemoradiotherapy (CRT) in stage III non-small cell lung cancer (NSCLC). Long-term data on mild to moderately severe cardiac events as underlying cause of dyspnoea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2f3e7749909281cd0d6cddcc4f00c2
https://cris.maastrichtuniversity.nl/en/publications/6669f08e-3943-41cd-ac9c-061e2c8c466f